IRadimed Corp
NASDAQ:IRMD
IRadimed Corp
EPS (Diluted)
IRadimed Corp
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IRadimed Corp
NASDAQ:IRMD
|
EPS (Diluted)
$1
|
CAGR 3-Years
172%
|
CAGR 5-Years
19%
|
CAGR 10-Years
22%
|
|
Becton Dickinson and Co
NYSE:BDX
|
EPS (Diluted)
$4
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
105%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$8
|
CAGR 3-Years
33%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$3
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$5
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is IRadimed Corp's EPS (Diluted)?
EPS (Diluted)
1.4
USD
Based on the financial report for Mar 31, 2024, IRadimed Corp's EPS (Diluted) amounts to 1.4 USD.
What is IRadimed Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
22%
Over the last year, the EPS (Diluted) growth was 29%. The average annual EPS (Diluted) growth rates for IRadimed Corp have been 172% over the past three years , 19% over the past five years , and 22% over the past ten years .